PAR 5.88% 24.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3445

  1. 2,137 Posts.
    lightbulb Created with Sketch. 574
    Drug Information

    Zycosan is the first injectable pentosan product to receive FDA approval for use in horses. Zycosan is FDA-approved for intramuscular use in horses.Zycosan is a heparin-like compound with anticoagulant and fibrinolytic effects. The mechanism of action for pentosan polysulfate sodium is unknown but is thought to include stimulation of hyaluronic acid and glycosaminoglycan synthesis in damaged joints, inhibition of proteolytic enzymes, and scavenging of free radicals. Pentosan polysulfate sodium may also modulate cytokine activity.

    Straight from the horses (FDA’s) mouth:


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
-0.015(5.88%)
Mkt cap ! $84.05M
Open High Low Value Volume
25.5¢ 26.5¢ 24.0¢ $167.2K 671.5K

Buyers (Bids)

No. Vol. Price($)
3 108741 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 9700 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.